These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24530099)

  • 1. The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders.
    Legrand F; Tomasevic N; Simakova O; Lee CC; Wang Z; Raffeld M; Makiya MA; Palath V; Leung J; Baer M; Yarranton G; Maric I; Bebbington C; Klion AD
    J Allergy Clin Immunol; 2014 May; 133(5):1439-47, 1447.e1-8. PubMed ID: 24530099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.
    Hamann J; Koning N; Pouwels W; Ulfman LH; van Eijk M; Stacey M; Lin HH; Gordon S; Kwakkenbos MJ
    Eur J Immunol; 2007 Oct; 37(10):2797-802. PubMed ID: 17823986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages.
    Waddell LA; Lefevre L; Bush SJ; Raper A; Young R; Lisowski ZM; McCulloch MEB; Muriuki C; Sauter KA; Clark EL; Irvine KM; Pridans C; Hope JC; Hume DA
    Front Immunol; 2018; 9():2246. PubMed ID: 30327653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglec-7 on peripheral blood eosinophils: Surface expression and function.
    Legrand F; Landolina N; Zaffran I; Emeh RO; Chen E; Klion AD; Levi-Schaffer F
    Allergy; 2019 Jul; 74(7):1257-1265. PubMed ID: 30690753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
    Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
    J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
    Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
    Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis.
    Trindade CJ; Sun X; Maric D; Sharma S; Komarow HD; Hourigan CS; Klion A; Maric I
    Cytometry B Clin Cytom; 2024 Sep; 106(5):370-382. PubMed ID: 38666394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.
    Caldwell JM; Collins MH; Stucke EM; Putnam PE; Franciosi JP; Kushner JP; Abonia JP; Rothenberg ME
    J Allergy Clin Immunol; 2014 Nov; 134(5):1114-24. PubMed ID: 25234644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Modeling of Eosinophil-Associated Diseases.
    Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
    Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.
    Wilson TM; Maric I; Shukla J; Brown M; Santos C; Simakova O; Khoury P; Fay MP; Kozhich A; Kolbeck R; Metcalfe DD; Klion AD
    J Allergy Clin Immunol; 2011 Nov; 128(5):1086-92.e1-3. PubMed ID: 21762978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition.
    Kobayashi Y; Chu HH; Bui DV; Yun Y; Nguyen LM; Mitani A; Suzuki K; Asako M; Kanda A; Iwai H
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
    Stein ML; Villanueva JM; Buckmeier BK; Yamada Y; Filipovich AH; Assa'ad AH; Rothenberg ME
    J Allergy Clin Immunol; 2008 Jun; 121(6):1473-83, 1483.e1-4. PubMed ID: 18410960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
    Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
    Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
    Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
    Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
    Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
    Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
    Tajima K; Katagiri T
    Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.